4.6 Review

Non-invasive in vivo imaging of pancreatic ß-cell function and survival - a perspective

Journal

ACTA PHYSIOLOGICA
Volume 204, Issue 2, Pages 178-185

Publisher

WILEY
DOI: 10.1111/j.1748-1716.2011.02301.x

Keywords

diabetes mellitus; fluorescence microscopy; in vivo optical imaging; islets of Langerhans; pancreatic ss-cell mass

Categories

Funding

  1. US National Institutes of Health [DK-58508, DK-075487, DK-084321]
  2. Karolinska Institutet
  3. Swedish Research Council
  4. Novo Nordisk Foundation
  5. Swedish Diabetes Association
  6. Berth von Kantzows Foundation
  7. Knut and Alice Wallenberg Foundation
  8. VIBRANT [FP7-228933-2]
  9. Skandia Insurance Company, Ltd.
  10. World Class University through the National Research Foundation of Korea
  11. Ministry of Education, Science and Technology [CR31-2008-000-10105-0]
  12. Family Erling-Persson Foundation
  13. Novo Nordisk Fonden [NNF11OC1014706, NNF12OC1016557] Funding Source: researchfish

Ask authors/readers for more resources

A major problem in medical research is to translate in vitro observations into the living organism. In this perspective, we discuss ongoing efforts to non-invasively image pancreatic islets/beta-cells by techniques, such as magnetic resonance imaging and positron emission tomography, and present an experimental platform, which allows in vivo imaging of pancreatic beta-cell mass and function longitudinally and at the single-cell level. Following transplantation of pancreatic islets into the anterior chamber of the eye of mice and rats, these islets are studied by functional microscopic imaging. This imaging platform can be utilized to address fundamental aspects of pancreatic islet cell biology in vivo in health and disease. These include the dynamics of pancreatic islet vascularization, islet cell innervation, signal-transduction, change in functional beta-cell mass and immune responses. Moreover, we discuss the feasibility of studying human islet cell physiology and pathology in vivo as well as the potential of using the anterior chamber of the eye as a site for therapeutic transplantation in type 1 diabetes mellitus.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available